Emmaus Life Sciences, Inc Employee Directory
Pharmaceutical ManufacturingCalifornia, United States11-50 Employees
Emmaus Life Sciences, Inc. operates as a biopharmaceutical company focused on discovering, developing, and commercializing therapies for rare and orphan diseases, with an initial focus on sickle cell disease. Its lead candidate is an oral L-glutamine formulation that has shown positive results in a completed Phase 3 trial for sickle cell anemia and sickle beta-0-thalassemia. Based in Torrance, California, the company positions itself within the pharmaceutical manufacturing sector as a small to mid-sized enterprise pursuing therapies for underserved patient populations. In early 2026 Emmaus restructured its U.S. operations and entered into a license and exclusive distribution arrangement with NeoImmuneTech, with full implementation expected in the second quarter of 2026. The arrangement underscores a move toward expanded distribution and collaboration to advance its rare disease portfolio.
1-888-653-2347 
support@leadiq.com 
